Jeffrey Alan Hawkins, SVP, Global Marketing & PM at GenMark Diagnostics, Inc. (GNMK), sold 74 shares at $11.47 ($849) on 2014-11-13, disclosed to the SEC on 2014-11-14.
Scheduled sale ($849) by SVP, Global Marketing & PM under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| QSI | SELL | 2026-04-22 | $168K | — | Filing → |
| QSI | SELL | 2026-03-24 | $40K | — | Filing → |
| QSI | SELL | 2025-12-22 | $30K | — | Filing → |